Cycurion (CYCU) files update on press release and NASDAQ-listed warrants
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Cycurion, Inc., a Delaware-based company listed on The NASDAQ Stock Market, filed an update to report that it issued a press release on December 5, 2025, which is furnished as Exhibit 99.1 under an “Other Events” section. The company’s listed securities include common stock trading under the symbol CYCU and redeemable warrants trading under CYCUW, with each warrant exercisable for one share of common stock at an exercise price of $345.00 per share.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did Cycurion (CYCU) report in this SEC filing?
Cycurion reported that it issued a press release on December 5, 2025, furnished as Exhibit 99.1. The filing categorizes this under “Other Events,” indicating an informational corporate update rather than a detailed financial report or major transaction disclosure.
Which securities of Cycurion (CYCU) are listed on NASDAQ?
Cycurion lists its common stock and redeemable warrants on The NASDAQ Stock Market. The common stock trades under symbol CYCU, while the warrants trade under CYCUW, each warrant exercisable for one share of common stock at an exercise price of $345.00.
What is included as Exhibit 99.1 in Cycurion’s December 2025 filing?
Exhibit 99.1 contains a press release dated December 5, 2025. This exhibit provides the substantive details of the company’s announcement, while the main report simply notes that the press release has been issued and furnished for investors’ reference.
How are Cycurion’s redeemable warrants (CYCUW) structured?
Cycurion’s redeemable warrants, trading under CYCUW, are each exercisable for one share of common stock. The filing specifies an exercise price of $345.00 per share, defining the cost to convert each warrant into a share when exercised according to its terms.
Who signed Cycurion’s December 2025 current report?
The report was signed on behalf of Cycurion by Chief Executive Officer L. Kevin Kelly. The signature block confirms that the registrant caused the report to be executed under the Securities Exchange Act of 1934 requirements on the stated December 2025 date.
